JPS6111932B2 - - Google Patents
Info
- Publication number
- JPS6111932B2 JPS6111932B2 JP4361279A JP4361279A JPS6111932B2 JP S6111932 B2 JPS6111932 B2 JP S6111932B2 JP 4361279 A JP4361279 A JP 4361279A JP 4361279 A JP4361279 A JP 4361279A JP S6111932 B2 JPS6111932 B2 JP S6111932B2
- Authority
- JP
- Japan
- Prior art keywords
- capsules
- capsule
- polymer resin
- emulsion polymer
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002775 capsule Substances 0.000 claims description 72
- 229920003002 synthetic resin Polymers 0.000 claims description 25
- 239000004908 Emulsion polymer Substances 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 23
- 229920005989 resin Polymers 0.000 claims description 19
- 239000011347 resin Substances 0.000 claims description 19
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- 238000007720 emulsion polymerization reaction Methods 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000004014 plasticizer Substances 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims 1
- 229920000591 gum Polymers 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 description 29
- 239000007903 gelatin capsule Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 238000000034 method Methods 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 6
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 229920003169 water-soluble polymer Polymers 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000003677 abuse test Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 239000001087 glyceryl triacetate Substances 0.000 description 3
- 235000013773 glyceryl triacetate Nutrition 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 229960002622 triacetin Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000008118 PEG 6000 Substances 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- -1 crotonic acid ester Chemical class 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000002702 enteric coating Substances 0.000 description 2
- 238000009505 enteric coating Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- GOJCZVPJCKEBQV-UHFFFAOYSA-N Butyl phthalyl butylglycolate Chemical compound CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC GOJCZVPJCKEBQV-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102220570135 Histone PARylation factor 1_L30D_mutation Human genes 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4361279A JPS55136061A (en) | 1979-04-12 | 1979-04-12 | Sheath capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4361279A JPS55136061A (en) | 1979-04-12 | 1979-04-12 | Sheath capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55136061A JPS55136061A (en) | 1980-10-23 |
| JPS6111932B2 true JPS6111932B2 (OSRAM) | 1986-04-05 |
Family
ID=12668652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4361279A Granted JPS55136061A (en) | 1979-04-12 | 1979-04-12 | Sheath capsule |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS55136061A (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003220551A1 (en) * | 2002-03-26 | 2003-10-13 | Euro-Celtique S.A. | Sustained-release gel coated compositions |
| US12214084B2 (en) | 2017-07-11 | 2025-02-04 | Qualicaps Co., Ltd. | Enteric hard capsule |
| JP7366893B2 (ja) | 2018-06-22 | 2023-10-23 | クオリカプス株式会社 | 腸溶性硬質カプセル |
-
1979
- 1979-04-12 JP JP4361279A patent/JPS55136061A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55136061A (en) | 1980-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10874619B2 (en) | Acid resistant capsules | |
| CA1199869A (en) | Preparation of aqueous alcoholic dispersions of ph sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same | |
| US3959540A (en) | Gastric juice resistant gelatin capsules and a process for the production thereof | |
| CA2800426C (fr) | Microgranules et microcomprimes resistants au detournement | |
| JP4780898B2 (ja) | ペクチンフィルム組成物 | |
| US3656997A (en) | Coated gelatin capsules and process for producing same | |
| TWI793141B (zh) | 腸溶性硬質膠囊 | |
| NO300758B1 (no) | Fremgangsmåte for fremstilling av en smaksmaskert tablett som kan tygges og som har egenskaper med regulert frigjörelse | |
| HU219350B (en) | Stabilizing acryl-polimer-type coating compositions for controlling release of drug and process for production its | |
| JPH0441422A (ja) | 大腸崩壊性硬質カプセル | |
| MXPA03001854A (es) | Capsula dura. | |
| AU3005800A (en) | Controlled release bupropion formulation | |
| US5149775A (en) | Method for purifying high molecular weight vinylpyridine/styrene polymers from solution | |
| KR20190027846A (ko) | 경도가 개선된 경질 캡슐 및 그 제조 방법 | |
| US20060165775A1 (en) | Capsule and film-forming composition comprising gum arabic | |
| US3041243A (en) | Sealing coat for tablets and the like | |
| Penning | Aqueous shellac solutions for controlled release coatings | |
| US3132075A (en) | Solid medicinal dosage forms coated with hydroxyethylcellulose and hydrolyzed styrene-maleic anhydride copolymer | |
| US3244596A (en) | Coated medicinal agents and coating compositions therefor | |
| KR20050028104A (ko) | 장용성의 수계 분산 히드록시프로필 메틸셀룰로오스프탈레이트 나노입자의 제조방법 | |
| CN1249951A (zh) | 含水包衣组合物和制备固体药物制剂的方法 | |
| CN1243539C (zh) | 稳定的肠溶性糖衣片的制造方法 | |
| JP2538491B2 (ja) | 味をマスキングされた薬物及びそれらの製法 | |
| EP3272341A1 (en) | Enteric elastic films for the production of capsules | |
| JPS5965011A (ja) | 有核錠 |